invokana

Generic: canagliflozin

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name invokana
Generic Name canagliflozin
Labeler a-s medication solutions
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

canagliflozin 300 mg/1

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-4364
Product ID 50090-4364_8f7706b7-8c1b-4c13-bb18-3ec25c98425f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA204042
Listing Expiration 2026-12-31
Marketing Start 2013-03-29

Pharmacologic Class

Classes
p-glycoprotein inhibitors [moa] sodium-glucose cotransporter 2 inhibitor [epc] sodium-glucose transporter 2 inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500904364
Hyphenated Format 50090-4364

Supplemental Identifiers

RxCUI
1373471 1373473
UNII
0SAC974Z85

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name invokana (source: ndc)
Generic Name canagliflozin (source: ndc)
Application Number NDA204042 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0)
source: ndc

Packages (1)

50090-4364-0 90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0)

Ingredients (1)

canagliflozin (300 mg/1)

Linked Drug Pages (1)

INVOKANA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8f7706b7-8c1b-4c13-bb18-3ec25c98425f", "openfda": {"unii": ["0SAC974Z85"], "rxcui": ["1373471", "1373473"], "spl_set_id": ["9679460c-55f7-4826-b55c-fe116f020358"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (50090-4364-0)", "package_ndc": "50090-4364-0", "marketing_start_date": "20190617"}], "brand_name": "INVOKANA", "product_id": "50090-4364_8f7706b7-8c1b-4c13-bb18-3ec25c98425f", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["P-Glycoprotein Inhibitors [MoA]", "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "50090-4364", "generic_name": "canagliflozin", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVOKANA", "active_ingredients": [{"name": "CANAGLIFLOZIN", "strength": "300 mg/1"}], "application_number": "NDA204042", "marketing_category": "NDA", "marketing_start_date": "20130329", "listing_expiration_date": "20261231"}